Learn More
Medchemexpress LLC V-9302 | 1855871-76-9 | 99.5% | 538.68 | 100 MG

Supplier: Medchemexpress LLC HY112683100MG
V-9302 is a competitive antagonist of transmembrane glutamine flux. It selectively and potently targets the amino acid transporter ASCT2 (SLC1A5) but not ASCT1, inhibiting ASCT2-mediated glutamine uptake in HEK-293 cells.
- Selectively targets the amino acid transporter ASCT2 (SLC1A5) over ASCT1.
- Inhibits glutamine uptake (IC50=9.6 μM) in HEK-293 cells.
- Pharmacological blockade of ASCT2 leads to attenuated cancer cell growth and proliferation, increases cell death, and increases oxidative stress.
- Prevents tumor growth in HCT-116 and HT29 xenograft models (75 mg/kg; i.p.; daily for 21 days).
- When combined with CB-839, it elicits strong growth inhibition in SNU398 and MHCC97H xenograft models.
- High purity: 99.46%.
- Intended for research use only, not for sale to patients.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.